Back

Inhibitory effect of Dolosigranulum pigrum and Corynebacterium pseudodiphtheriticum on pneumococcal in vitro growth

Cisneros, M.; Blanco-Fuertes, M.; Lluansi, A.; Brotons, P.; Henares, D.; Perez-Argüello, A.; Gonzalez-Comino, G.; Ciruela, P.; Mira, A.; Munoz-Almagro, C.

2025-01-13 microbiology
10.1101/2025.01.10.632320 bioRxiv
Show abstract

BackgroundStreptococcus pneumoniae is a nasopharynx coloniser that can invade sterile tissues, causing Invasive Pneumococcal Disease (IPD). Dolosigranulum pigrum and Corynebacterium pseudodiphtheriticum are commensal bacteria commonly isolated from the nasopharynx of healthy children, potentially playing a protective role. This study aims to analyse the effects of D. pigrum and C. pseudodiphtheriticum on S. pneumoniae in vitro growth. MethodsPneumococcal strains were collected from IPD patients and healthy carriers in Catalonia (2016-2023). D. pigrum and C. pseudodiphtheriticum strains were isolated from a healthy childs nasopharynx. S. pneumoniae was co-cultured with each commensal bacterium in triplicate experiments. Pneumococcal growth was quantified using a real-time PCR assay targeting the lytA gene. The effect of commensal bacteria on pneumococcal growth was evaluated using a linear mixed-effect regression model. ResultsTwenty-eight pneumococcal strains expressing 24 different serotypes and 26 clonal types were analysed (18 isolated in blood and 10 in nasopharyngeal aspirate). Pneumococcal growth was decreased by D. pigrum ({beta} = -0.763, 95% CI: -0.94 to -0.59, p < 0.0001) and C. pseudodiphtheriticum ({beta} = -0.583, 95% CI: -0.76 to -0.41, p < 0.0001). The combined presence of both had a stronger inhibitory effect ({beta} = -0.971, 95% CI: -1.15 to -0.79, p < 0.0001). No association was found between isolation site or serotype with pneumococcal growth. ConclusionD. pigrum and C. pseudodiphtheriticum significantly reduced pneumococcal growth, with a synergic effect when combined. This antagonistic effect supports the potential protective factor of healthy nasopharyngeal microbiota against IPD and the development of these microorganisms as probiotics.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Microorganisms
101 papers in training set
Top 0.1%
18.4%
2
mSphere
281 papers in training set
Top 0.6%
6.3%
3
The Journal of Infectious Diseases
182 papers in training set
Top 0.7%
4.8%
4
Microbiology Spectrum
435 papers in training set
Top 0.5%
4.3%
5
Antibiotics
32 papers in training set
Top 0.3%
4.3%
6
Frontiers in Microbiology
375 papers in training set
Top 2%
4.3%
7
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 1%
3.6%
8
Journal of Infection
71 papers in training set
Top 0.5%
3.6%
9
Scientific Reports
3102 papers in training set
Top 42%
3.0%
50% of probability mass above
10
PLOS ONE
4510 papers in training set
Top 43%
2.9%
11
mSystems
361 papers in training set
Top 4%
2.6%
12
Vaccine
189 papers in training set
Top 0.9%
2.3%
13
mBio
750 papers in training set
Top 6%
2.1%
14
Journal of Global Antimicrobial Resistance
15 papers in training set
Top 0.3%
2.1%
15
Clinical Infectious Diseases
231 papers in training set
Top 2%
1.9%
16
Infection and Immunity
103 papers in training set
Top 0.4%
1.6%
17
Clinical Microbiology and Infection
60 papers in training set
Top 0.7%
1.3%
18
Vaccines
196 papers in training set
Top 2%
1.3%
19
BMC Microbiology
35 papers in training set
Top 0.9%
1.2%
20
Journal of Medical Microbiology
20 papers in training set
Top 0.4%
1.2%
21
Journal of Medical Virology
137 papers in training set
Top 4%
0.9%
22
Frontiers in Pediatrics
29 papers in training set
Top 0.8%
0.8%
23
BMC Infectious Diseases
118 papers in training set
Top 5%
0.8%
24
PeerJ
261 papers in training set
Top 15%
0.7%
25
European Journal of Clinical Microbiology & Infectious Diseases
15 papers in training set
Top 0.2%
0.7%
26
Microbiological Research
19 papers in training set
Top 0.7%
0.7%
27
Microbial Pathogenesis
13 papers in training set
Top 0.7%
0.7%
28
Microbiology
57 papers in training set
Top 1%
0.7%
29
Antimicrobial Agents and Chemotherapy
167 papers in training set
Top 2%
0.7%
30
Pathogens
53 papers in training set
Top 2%
0.7%